2.62 USD
+0.09 (+3.56%)
2.62 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to CMMB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.03. This target is 931.68% above the current price.
CMMB was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CMMB.
In the previous month the buy percentage consensus was at a similar level.
CMMB was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-02-20 | Maxim Group | Maintains | Buy -> Buy |
| 2024-11-15 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-13 | Maxim Group | Initiate | Buy |
| 2024-05-06 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2024-03-08 | Oppenheimer | Maintains | Perform -> Perform |
| 2023-12-19 | Roth MKM | Reiterate | Buy |
| 2023-10-06 | Roth MKM | Initiate | Buy |
| 2023-06-07 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-04-18 | Oppenheimer | Maintains | Outperform |
| 2022-03-10 | Oppenheimer | Maintains | Outperform |
| 2021-12-07 | Aegis Capital | Initiate | Buy |
| 2021-05-26 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-05-07 | Oppenheimer | Initiate | Outperform |
CHEMOMAB THERAPEUTICS LTD / CMMB FAQ
What do analysts expect the price target to be for CHEMOMAB THERAPEUTICS LTD (CMMB)?
8 analysts have analysed CMMB and the average price target is 27.03 USD. This implies a price increase of 931.68% is expected in the next year compared to the current price of 2.62.
What is the consensus rating for CHEMOMAB THERAPEUTICS LTD (CMMB) stock?
The consensus rating for CHEMOMAB THERAPEUTICS LTD (CMMB) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.